Search Within

Soo Ryum Yang

Formats
  1. Meeting Abstract (43)
  2. Journal Article (33)
  3. Review (8)
  4. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (85)
  2. Department of Medicine (69)
  3. Solid Tumor Oncology Division (69)
  4. Thoracic Oncology (66)
  5. GSK Faculty (59)
  6. Human Oncology and Pathogenesis Program (51)

More Groups

People
  1. Marc Ladanyi (47)
  2. Alexander Drilon (33)
  3. Jason Chang (33)
  4. Natasha Rekhtman (30)
  5. Michael Offin (26)
  6. William Travis (26)

More People

Years
  1. 2025 (16)
  2. 2024 (14)
  3. 2023 (19)
  4. 2022 (14)
  5. 2021 (16)
  6. 2020 (6)
Publications
  1. Laboratory Investigation (16)
  2. Journal of Thoracic Oncology (12)
  3. Journal of Clinical Oncology (11)
  4. Modern Pathology (8)
  5. Clinical Cancer Research (4)
  6. Journal of Molecular Diagnostics (4)

More Publications

Publishers
  1. Nature Publishing Group (22)
  2. American Society of Clinical Oncology (14)
  3. Elsevier Inc. (13)
  4. Nature Research (9)
  5. American Association for Cancer Research (7)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability and mismatch repair deficiency in smoking-associated lung carcinoma
    Meeting Abstract

    Yang, S. R.; Chang, J.; Gedvilaite, E.; Ziegler, J.; Sauter, J.; Rekhtman, N.; Travis, W.; Ladanyi, M.
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Utility of dual YAP/TAZ-NF2 immunohistochemistry in the diagnosis of malignant pleural mesothelioma and in predicting NF2 mutations
    Meeting Abstract

    Li, Y.; Chen, Y. B.; Zauderer, M.; Chang, J.; Offin, M.; Ladanyi, M.; Rekhtman, N.; Travis, W.; Yang, S. R.; Adusumilli, P.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Interpretation of methylthioadenosine phosphorylase (MTAP) expression by immunohistochemistry in malignant pleural mesothelioma is improved with monoclonal antibody 1813 compared to monoclonal antibody EPR6893
    Meeting Abstract

    Febres-Aldana, C.; Jungbluth, A.; Adusumilli, P.; Buonocore, D.; Chang, J.; Frosina, D.; Geronimo, J.; Hernandez, E.; Offin, M.; Rekhtman, N.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Correlation of histologic features with gene alterations in malignant pleural mesothelioma
    Meeting Abstract

    Yang, S. R.; Hsu, M.; Tan, K. S.; Adusumilli, P.; Chang, J.; Offin, M.; Rekhtman, N.; Travis, W.; Zauderer, M.; Ladanyi, M.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency in smoking-associated lung carcinoma
    Meeting Abstract

    Yang, S. R.; Chang, J.; Gedvilaite, E.; Ziegler, J.; Sauter, J.; Rekhtman, N.; Travis, W.; Ladanyi, M.
    Laboratory Investigation (2021)

    Fulltext@MSK | Save
  • Correlation of histologic features with gene alterations in malignant pleural mesothelioma
    Meeting Abstract

    Yang, S. R.; Hsu, M.; Tan, K. S.; Adusumilli, P.; Chang, J.; Offin, M.; Rekhtman, N.; Travis, W.; Zauderer, M.; Ladanyi, M.; more...
    Laboratory Investigation (2021)

    Fulltext@MSK | Save
  • Interpretation of methylthioadenosine phosphorylase (MTAP) expression by immunohistochemistry in malignant pleural mesothelioma is improved with monoclonal antibody 1813 compared to monoclonal antibody EPR6893
    Meeting Abstract

    Febres-Aldana, C.; Jungbluth, A.; Adusumilli, P.; Buonocore, D.; Chang, J.; Frosina, D.; Geronimo, J.; Hernandez, E.; Offin, M.; Rekhtman, N.; more...
    Laboratory Investigation (2021)

    Fulltext@MSK | Save
  • Utility of dual YAP/TAZ-NF2 immunohistochemistry in the diagnosis of malignant pleural mesothelioma and in predicting NF2 mutations
    Meeting Abstract

    Li, Y.; Chen, Y. B.; Zauderer, M.; Chang, J.; Offin, M.; Ladanyi, M.; Rekhtman, N.; Travis, W.; Yang, S. R.; Adusumilli, P.; more...
    Laboratory Investigation (2021)

    Fulltext@MSK | Save
  • A performance comparison of commonly used assays to detect RET fusions
    Journal Article

    Yang, S. R.; Aypar, U.; Rosen, E. Y.; Mata, D. A.; Benayed, R.; Mullaney, K.; Jayakumaran, G.; Zhang, Y.; Frosina, D.; Drilon, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic characterization of a RET inhibitor–resistant RET fusion–positive lung cancer by CSF cell-free DNA hybrid capture–based sequencing
    Journal Article

    Choudhury, N. J.; Yang, S. R.; Arcila, M.; Mohanty, A. S.; Boire, A.; Drilon, A.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save